已收盤 02-06 16:00:00 美东时间
+1.920
+2.92%
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Citigroup analyst Andrew Kaplowitz maintains Atkore (NYSE:ATKR) with a Neutral and raises the price target from $64 to $74.
02-05 00:08
Atkore Inc 2026财年一季报营收6.56亿美元,同比下降0.9%;归母净利润0.15亿美元,同比下滑67.6%
02-03 20:16
华盛资讯2月3日讯,Atkore Inc公布2025财年Q4业绩,公司Q4营收6.56亿美元,同比下降0.9%,归母净利润0.15亿美元,同比下滑67.4%。
02-03 20:02
Atkore (NYSE:ATKR) reported its Q1 earnings results on Tuesday, February 3, 202...
02-03 19:56
The Q1 earnings report for Atkore (NYSE:ATKR) was released on Tuesday, February...
02-03 19:50
Atkore (NYSE:ATKR) announced its Q1 earnings on Tuesday, February 3, 2026 at 06...
02-03 19:44
Atkore (NYSE:ATKR) released its Q1 earnings on Tuesday, February 3, 2026 at 06:...
02-03 19:24
Atkore (NYSE:ATKR) affirms FY2026 Adj EPS guidance from $5.05-$5.55 to $5.05-$5.55 vs $5.18 analyst estimate..
02-03 19:21
The Q1 earnings report for Atkore (NYSE:ATKR) was released on Tuesday, February...
02-03 19:18